Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

3 articles from the last 30 days matching "genetic testing"

ResearchPUBMEDApr 16

Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation.

Scientists created a new tool called STRIPE that uses advanced genetic testing to read long strands of RNA (the instructions cells use to make proteins). This tool can detect genetic mistakes that cause rare diseases by looking at how genes are actually working in cells, not just finding the mutations themselves. It's designed to be faster, cheaper, and more practical than older methods, which could help doctors diagnose rare genetic diseases that are hard to identify.

WHY IT MATTERSPatients with undiagnosed rare genetic diseases could finally get answers through more accurate genetic testing, since STRIPE can detect disease-causing variants that standard DNA tests might miss.
Good to knowRead →
ResearchCONGRESSApr 1

AAN 2026: Social Determinants of Health, the Diagnostic Odyssey, and Genetic Testing for Global Developmental Delay/Intellectual Disability: A Qualitative Study.

Researchers studied how life circumstances like poverty, access to healthcare, and education affect children with developmental delays and intellectual disabilities. They also looked at how long it takes families to get a diagnosis and whether genetic testing helps. The study suggests that where you live and your resources matter a lot in getting answers for why a child has developmental challenges.

WHY IT MATTERSThis research highlights that children from disadvantaged backgrounds face longer diagnostic journeys for developmental delays—meaning families may wait years longer to understand their child's condition and access support services.
Good to knowGlobal Developmental DelayIntellectual DisabilityRead →
ResearchPUBMEDApr 1

Expanding Access to Genome Sequencing: Higher Diagnostic Yield in Self-Referred Participants From the CincyKidsSeq Study and Implications for Hybrid Models of Genetic Service Delivery.

Researchers tested whether people could get genetic testing (genome sequencing) without always needing to see a genetics specialist first. They studied 313 people of all ages who had unexplained symptoms and could refer themselves or be referred by any doctor. The study found that people who referred themselves were just as likely to get a diagnosis as those referred by specialists. This suggests a new way to make genetic testing available to more people while still having genetics experts review the results.

WHY IT MATTERSIf this hybrid model works, patients with rare diseases could access genome sequencing faster and more easily without waiting for a genetics specialist appointment, potentially shortening the diagnostic odyssey that many rare disease patients experience.
💬 Ask your doctorrare genetic diseasesundiagnosed genetic conditionsRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases